Taiwan FDA registration a9d64d9021166213bdd1217975e3f851
Iminoglycemin radioimmunoassay reagent
TW: 伊敏升糖素放射免疫分析試劑
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Dec 08, 2010 – Dec 08, 2015CancelledRegistration details
- Analysis ID
- a9d64d9021166213bdd1217975e3f851
- Customs Code
- DHAS0602192307
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- ALICE LEE INDUSTRIES CO., LTD.
Product details
- Intended Use
- 利用放射免疫分析法定量檢測人體血漿(with EDTA)之Glucagon.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1335 Glycemon Test System
- Import Information
- Imports must be accompanied by a letter of consent (a certificate of approval of the Atomic Energy Commission shall be attached to each batch of imports); input
Dates and status
- Registration Date
- Dec 08, 2010
- Expiry Date
- Dec 08, 2015
- Cancellation Date
- Jul 31, 2018
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for Iminoglycemin radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a9d64d9021166213bdd1217975e3f851 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is ALICE LEE INDUSTRIES CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices